[Gyrase inhibitor].
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D002937:Cinoxacin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D009268:Nalidixic Acid / Q000494:pharmacology; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology; D010876:Pipemidic Acid / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D015363:Quinolones; D013329:Structure-Activity Relationship; D059005:Topoisomerase II Inhibitors
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D010078:Oxazines; D011804:Quinolines; D015363:Quinolones; D059005:Topoisomerase II Inhibitors; D009268:Nalidixic Acid; C021083:rosoxacin; D015242:Ofloxacin; D002937:Cinoxacin; D010876:Pipemidic Acid
Gyrase-Hemmer.